Sort
40,608 grants matching “prostate cancer”
Molecular mechanisms of prostate cancer metastasis
$473,852Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2025 · CA
Molecular mechanisms of prostate cancer metastasis
$473,850Cory Abate-Shen · Columbia University Health Sciences · R01 · FY2021 · CA
FATTY ACID SYNTHASE: STRUCTURE, DYNAMICS AND FUNCTION
$473,731Florante A Quiocho · Baylor College Of Medicine · R01 · FY2007 · GM
Rational in situ programming of cancer vaccine-responding T-cell clones
$473,651Matthias Stephan · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Vitamin D and Prostate Cancer: Biomarkers and Genetic Variation
$473,541Marian L Neuhouser · Fred Hutchinson Cancer Research Center · R01 · FY2010 · CA
PSMA Antibody-Drug Conjugate for Prostate Cancer Therapy
$473,537Dangshe Ma · Progenics Pharmaceuticals, Inc. · R44 · FY2007 · CA
Project 2: Investigating cell intrinsic and extrinsic drivers of prostate cancer bone metastasis
$473,522Cory Abate-Shen · Columbia University Health Sciences · P01 · FY2023 · CA
Nanoscintillator-based X-ray sensitizers to enable efficient NSCLC treatment with X-ray irradiation
$473,515Jin Xie · University Of Georgia · R01 · FY2019 · EB
EFFECTS OF RADIATION ON PROTEASOME FUNCTION IN PROSTATE CANCER CELLS
$473,505University Of California, Los Angeles · · FY2008 · Department of Defense
The Early Detection Research Network: Biomarker Referen*
$473,491David S Chia · University Of California Los Angeles · U24 · FY2008 · CA
Increasing Recruitment of underrepresented cancer survivors with awareness enhancing interventions (RUN AWEI)
$473,444Michelle Y Martin · University Of Tennessee Health Sci Ctr · R01 · FY2021 · CA
Determining the clinical impact of gene expression testing in localized prostate cancer
$473,428Todd M. Morgan · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Core-Biomarker Development Laboratory
$473,371Paul Christopher Boutros · Eastern Virginia Medical School · U2C · FY2022 · CA
Novel Therapeutic Strategies to Co-Target Undifferentiated Prostate Cancer (PCa) Stem Cells and Bulk PCa Cells
$473,358Dean G Tang · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
A NESTED CASE-CONTROL STUDY OF PROSTATE CARCINOGENESIS
$473,334Benjamin A. Rybicki · Henry Ford Health System · R01 · FY2017 · ES
INHIBITION OF ANDROGEN-INDEPENDENT ACTIVATION OF THE AR IN PROSTATE CANCER
$473,292Mayo Clinic · · FY2009 · Department of Defense
Photodestruction of Ovarian Cancer: ErbB3 Targeted Aptamer Nanoparticle Conjugate
$473,223Tayyaba Hasan · Massachusetts General Hospital · R01 · FY2007 · CA
HOMING PEPTIDES FOR THE VASCULATURE IN PROSTATE
$473,208Erkki I Ruoslahti · University Of California, San Diego · P01 · FY2009 · CA
CNP for Older Underserved African American Adults
$473,207Terrance L. Albrecht · Wayne State University · U01 · FY2008 · CA
Enhanced imaging and treatment of aggressive subtypes of prostate cancer
$473,165Martin G Pomper · Johns Hopkins University · R01 · FY2020 · CA
IDENTIFICATION OF SIGLEC 9 LIGAND FOR T CELL IMMUNOEVASION IN ADVANCED PROSTATE CANCER
$473,100The Leland Stanford Junior University · · FY2021 · Defense Health Agency
Phase I Clinical Trials of Novel Agents
$473,057Naiyer A Rizvi · Sloan-Kettering Inst Can Research · U01 · FY2006 · CA
Anti-tumor Mechanisms & Therapeutic Effects of Vitamin D
$473,024Candace S Johnson · Roswell Park Cancer Institute Corp · R01 · FY2006 · CA
Development of nanoparticulate solution for cancer treatment by breakup of tumor extracellular hydroxyapatite: a new paradigm
$472,960Mohammed Noor Tantawy · Vanderbilt University Medical Center · R21 · FY2021 · CA
HOWARD UNIVERSITY CANCER CENTER PLANNING GRANT
$472,933Howard University · P20 · FY2002 · CA